Ines Bartolo
Lisbon, 1649003, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Longitudinal Analysis of HIV-2 Proviral DNA Reveals Archived Protease Inhibitor Resistance and Reservoir Evolution over Eight Years.
Journal: International journal of molecular sciences
Published: April 15, 2026
An HIV-1/HIV-2 Chimeric Envelope Glycoprotein Generates Binding and Neutralising Antibodies against HIV-1 and HIV-2 Isolates.
Journal: International journal of molecular sciences
Published: April 03, 2023
Antiretroviral Treatment of HIV-2 Infection: Available Drugs, Resistance Pathways, and Promising New Compounds.
Journal: International journal of molecular sciences
Published: January 24, 2023
Long-Term and Low-Level Envelope C2V3 Stimulation by Highly Diverse Virus Isolates Leads to Frequent Development of Broad and Elite Antibody Neutralization in HIV-1-Infected Individuals.
Journal: Microbiology spectrum
Published: November 29, 2022
High Instantaneous Inhibitory Potential of Bictegravir and the New Spiro-β-Lactam BSS-730A for HIV-2 Isolates from RAL-Naïve and RAL-Failing Patients.
Journal: International journal of molecular sciences
Published: October 06, 2022
Unveiling a family of spiro-β-lactams with anti-HIV and antiplasmodial activity via phosphine-catalyzed [3+2] annulation of 6-alkylidene-penicillanates and allenoates.
Journal: Frontiers in chemistry
Published: August 11, 2022
Keratinocyte Growth Factor-Based Strategies for Wound Re-Epithelialization.
Journal: Tissue engineering. Part B, Reviews
Published: July 09, 2021
Synthesis and structure-activity relationships of new chiral spiro-β-lactams highly active against HIV-1 and Plasmodium.
Journal: European journal of medicinal chemistry
Published: March 03, 2021
Spiro-β-lactam BSS-730A Displays Potent Activity against HIV and Plasmodium.
Journal: ACS infectious diseases
Published: January 04, 2021
Anti-HIV-1 Activity of pepRF1, a Proteolysis-Resistant CXCR4 Antagonist Derived from Dengue Virus Capsid Protein.
Journal: ACS infectious diseases
Published: December 15, 2020
Last Updated: 09/26/2026